Review



primary rabbit anti- anoctamin- 1  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Alomone Labs primary rabbit anti- anoctamin- 1
    Primary Rabbit Anti Anoctamin 1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/Anti-TMEM16A+(ANO1)+(extracellular)+Antibody/pm42277581-77-29-38
    Average 93 stars, based on 12 article reviews
    primary rabbit anti- anoctamin- 1 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Immunofluorescence:

    Article Title: Orai1 calcium channel inhibition prevents progression of chronic pancreatitis
    Article Snippet: Images were captured by Zeiss Axio Imager.M2 microscope (Carl Zeiss Microscopy) with 2.5 × objective (Zeiss, NA: 0.07), 5 × objective (Zeiss, NA: 0.15), 20 × objective (Zeiss, NA: 0.8), and 40 × objective (Zeiss, NA: 0.75); they were then subsequently analyzed. .. For immunofluorescence staining, whole samples were frozen and cut at –20°C; they were then fixed in 4% paraformaldehyde (PFA) or PSCs seeded onto cover glasses were fixed in 4% PFA and labeled with primary antibodies overnight (anti–α-SMA, Novus Biologicals, NB300-978; anti-CFTR, Alomone labs, ACL-006; anti-GFAP, Invitrogen, PA1-10004; anti-Occludin, Invitrogen, 33-1500; anti-Orai1, abcam, ab59330; anti-Orai1, Novus Biologicals, NBP1-75522; anti-PARP, Novus Biologicals, NB100-56599; anti-pHH3, Sigma-Aldrich, 06-570; anti-TMEM66, Invitrogen, PA5-31588; anti-VIM, Invitrogen, MA3745). .. Then, they were labeled with secondary antibodies for 2 hours (donkey anti–goat Alexa Fluor 488, Abcam, ab150129; donkey anti–mouse Alexa Fluor 647, Invitrogen, A31571; goat anti–mouse Alexa Fluor 488, Invitrogen, A48286; goat anti–mouse Alexa Fluor 555, Invitrogen, A48287; goat anti–mouse Alexa Fluor 647, Invitrogen, A48289; goat anti–rabbit Alexa Fluor 488, Invitrogen, A48282; goat anti–rabbit Alexa Fluor 647, Invitrogen, A48285; goat anti–chicken Alexa Fluor 647, Invitrogen, A32933).

    Staining:

    Article Title: Orai1 calcium channel inhibition prevents progression of chronic pancreatitis
    Article Snippet: Images were captured by Zeiss Axio Imager.M2 microscope (Carl Zeiss Microscopy) with 2.5 × objective (Zeiss, NA: 0.07), 5 × objective (Zeiss, NA: 0.15), 20 × objective (Zeiss, NA: 0.8), and 40 × objective (Zeiss, NA: 0.75); they were then subsequently analyzed. .. For immunofluorescence staining, whole samples were frozen and cut at –20°C; they were then fixed in 4% paraformaldehyde (PFA) or PSCs seeded onto cover glasses were fixed in 4% PFA and labeled with primary antibodies overnight (anti–α-SMA, Novus Biologicals, NB300-978; anti-CFTR, Alomone labs, ACL-006; anti-GFAP, Invitrogen, PA1-10004; anti-Occludin, Invitrogen, 33-1500; anti-Orai1, abcam, ab59330; anti-Orai1, Novus Biologicals, NBP1-75522; anti-PARP, Novus Biologicals, NB100-56599; anti-pHH3, Sigma-Aldrich, 06-570; anti-TMEM66, Invitrogen, PA5-31588; anti-VIM, Invitrogen, MA3745). .. Then, they were labeled with secondary antibodies for 2 hours (donkey anti–goat Alexa Fluor 488, Abcam, ab150129; donkey anti–mouse Alexa Fluor 647, Invitrogen, A31571; goat anti–mouse Alexa Fluor 488, Invitrogen, A48286; goat anti–mouse Alexa Fluor 555, Invitrogen, A48287; goat anti–mouse Alexa Fluor 647, Invitrogen, A48289; goat anti–rabbit Alexa Fluor 488, Invitrogen, A48282; goat anti–rabbit Alexa Fluor 647, Invitrogen, A48285; goat anti–chicken Alexa Fluor 647, Invitrogen, A32933).

    Labeling:

    Article Title: Orai1 calcium channel inhibition prevents progression of chronic pancreatitis
    Article Snippet: Images were captured by Zeiss Axio Imager.M2 microscope (Carl Zeiss Microscopy) with 2.5 × objective (Zeiss, NA: 0.07), 5 × objective (Zeiss, NA: 0.15), 20 × objective (Zeiss, NA: 0.8), and 40 × objective (Zeiss, NA: 0.75); they were then subsequently analyzed. .. For immunofluorescence staining, whole samples were frozen and cut at –20°C; they were then fixed in 4% paraformaldehyde (PFA) or PSCs seeded onto cover glasses were fixed in 4% PFA and labeled with primary antibodies overnight (anti–α-SMA, Novus Biologicals, NB300-978; anti-CFTR, Alomone labs, ACL-006; anti-GFAP, Invitrogen, PA1-10004; anti-Occludin, Invitrogen, 33-1500; anti-Orai1, abcam, ab59330; anti-Orai1, Novus Biologicals, NBP1-75522; anti-PARP, Novus Biologicals, NB100-56599; anti-pHH3, Sigma-Aldrich, 06-570; anti-TMEM66, Invitrogen, PA5-31588; anti-VIM, Invitrogen, MA3745). .. Then, they were labeled with secondary antibodies for 2 hours (donkey anti–goat Alexa Fluor 488, Abcam, ab150129; donkey anti–mouse Alexa Fluor 647, Invitrogen, A31571; goat anti–mouse Alexa Fluor 488, Invitrogen, A48286; goat anti–mouse Alexa Fluor 555, Invitrogen, A48287; goat anti–mouse Alexa Fluor 647, Invitrogen, A48289; goat anti–rabbit Alexa Fluor 488, Invitrogen, A48282; goat anti–rabbit Alexa Fluor 647, Invitrogen, A48285; goat anti–chicken Alexa Fluor 647, Invitrogen, A32933).

    Recombinant:

    Article Title: AAV gene therapy rescues hearing and balance in a model of CLIC5 deafness
    Article Snippet: .. Reagents and tools table Experimental models C57BL/6JClic5nmf318/J Jackson Laboratory #005329 Recombinant DNA ssAAV9/PHP.B -CB6-Clic5-3XFLAGP2A-TurboGFPWPRE Viral Vector Core at Boston Children’s Hospital N/A scAAV9/PHP.B -CB6-Clic5-3XFLAGP2A-TurboGFPWPRE Viral Vector Core at Boston Children’s Hospital N/A ssAAV9/PHP.B -CB6-TurboGFPWPRE_Control Viral Vector Core at Boston Children’s Hospital N/A scAAV9/PHP.B -CB6-TurboGFPWPRE_Control Viral Vector Core at Boston Children’s Hospital N/A Antibodies Polyclonal Myosin VIIa Proteus Biosciences cat# 25‐6790 ANTI-CLIC5 Alomone Labs cat# ACL-025 Monoclonal ANTIFLAG Sigma cat# F3165 ANTI-TPRN Sigma cat# HPA020899 ANTI-Radixin Sigma cat# R3653 Goat Anti-Mouse IgG H&L (Alexa Fluor® 405) Abcam cat# ab175660 Goat Anti-Mouse IgG H&L (Alexa Fluor® 647) Abcam cat# ab150119 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) Abcam cat# ab150081 Figure 6. ..

    Article Title: RIPOR2-mediated autophagy dysfunction is critical for aminoglycoside-induced hearing loss.
    Article Snippet: In brief Li et al. find that aminoglycoside binds to and triggers rapid translocation of RIPOR2 in cochlear hair cells.. RIPOR2 interacts with the core autophagy component GABARAP and affects autophagy activation.. Inhibiting this pathway prevents aminoglycosideinduced hearing loss, and this suggests that autophagy pathway components are potential therapeutic targets for preventing aminoglycoside ototoxicity.

    Western Blot:

    Article Title: Structural heterogeneity of the ion and lipid channel TMEM16F
    Article Snippet: .. Anti-TMEM16B (1 citation), Human, rat and mouse, WB, IFC, LCI and IF (https://www.alomone.com/p/anti-anoctamin-6-extracellular/ ACL-016). ..

    Article Title: RIPOR2-mediated autophagy dysfunction is critical for aminoglycoside-induced hearing loss.
    Article Snippet: In brief Li et al. find that aminoglycoside binds to and triggers rapid translocation of RIPOR2 in cochlear hair cells.. RIPOR2 interacts with the core autophagy component GABARAP and affects autophagy activation.. Inhibiting this pathway prevents aminoglycosideinduced hearing loss, and this suggests that autophagy pathway components are potential therapeutic targets for preventing aminoglycoside ototoxicity.

    other:

    Article Title: AAV gene therapy rescues hearing and balance in a model of CLIC5 deafness
    Article Snippet: ANTI-CLIC5 , Alomone Labs , cat# ACL-025.

    Generated:

    Article Title: RIPOR2-mediated autophagy dysfunction is critical for aminoglycoside-induced hearing loss.
    Article Snippet: In brief Li et al. find that aminoglycoside binds to and triggers rapid translocation of RIPOR2 in cochlear hair cells.. RIPOR2 interacts with the core autophagy component GABARAP and affects autophagy activation.. Inhibiting this pathway prevents aminoglycosideinduced hearing loss, and this suggests that autophagy pathway components are potential therapeutic targets for preventing aminoglycoside ototoxicity.

    Virus:

    Article Title: RIPOR2-mediated autophagy dysfunction is critical for aminoglycoside-induced hearing loss.
    Article Snippet: In brief Li et al. find that aminoglycoside binds to and triggers rapid translocation of RIPOR2 in cochlear hair cells.. RIPOR2 interacts with the core autophagy component GABARAP and affects autophagy activation.. Inhibiting this pathway prevents aminoglycosideinduced hearing loss, and this suggests that autophagy pathway components are potential therapeutic targets for preventing aminoglycoside ototoxicity.

    Subcloning:

    Article Title: RIPOR2-mediated autophagy dysfunction is critical for aminoglycoside-induced hearing loss.
    Article Snippet: In brief Li et al. find that aminoglycoside binds to and triggers rapid translocation of RIPOR2 in cochlear hair cells.. RIPOR2 interacts with the core autophagy component GABARAP and affects autophagy activation.. Inhibiting this pathway prevents aminoglycosideinduced hearing loss, and this suggests that autophagy pathway components are potential therapeutic targets for preventing aminoglycoside ototoxicity.



    Similar Products

    95
    MedChemExpress acly inhibitor bms 303141
    ACLY activity regulates MDR1 expression in colorectal cancer. (A) Transcript levels of ACLY and MDR1 (ABCB1) in colorectal cancer (red) and normal colon tissues (grey) analyzed using GEPIA (TCGA/GTEx datasets). (B) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the ACLY <t>inhibitor</t> <t>BMS-303141</t> (20 or 50 μM, 48 h). (C) Immunoblot analysis of ACLY and MDR1 in SW480 and DLD1 cells transduced with empty vector (pLV) or ACLY-overexpressing vector (pLV[Exp]-hACLY). (D) Immunoblot analysis of ACLY and MDR1 in control and ACLY-overexpressing cells treated with BMS-303141 (50 μM, 48 h). (E) Relative ABCB1 mRNA levels in control and ACLY-overexpressing cells, and in cells treated with BMS-303141. (F) Relative ACLY mRNA levels under the same conditions. Data are presented as mean ± SD (n = 3 unless otherwise indicated). Statistical significance was determined using unpaired two-tailed t-tests or one-way ANOVA with Tukey’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.
    Acly Inhibitor Bms 303141, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/BMS-303141/pmc13142016-38-1-4
    Average 95 stars, based on 1 article reviews
    acly inhibitor bms 303141 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    86
    Arthrex Inc acl femoral guide
    ACLY activity regulates MDR1 expression in colorectal cancer. (A) Transcript levels of ACLY and MDR1 (ABCB1) in colorectal cancer (red) and normal colon tissues (grey) analyzed using GEPIA (TCGA/GTEx datasets). (B) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the ACLY <t>inhibitor</t> <t>BMS-303141</t> (20 or 50 μM, 48 h). (C) Immunoblot analysis of ACLY and MDR1 in SW480 and DLD1 cells transduced with empty vector (pLV) or ACLY-overexpressing vector (pLV[Exp]-hACLY). (D) Immunoblot analysis of ACLY and MDR1 in control and ACLY-overexpressing cells treated with BMS-303141 (50 μM, 48 h). (E) Relative ABCB1 mRNA levels in control and ACLY-overexpressing cells, and in cells treated with BMS-303141. (F) Relative ACLY mRNA levels under the same conditions. Data are presented as mean ± SD (n = 3 unless otherwise indicated). Statistical significance was determined using unpaired two-tailed t-tests or one-way ANOVA with Tukey’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.
    Acl Femoral Guide, supplied by Arthrex Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/acl+guide+tibial/pm42312912-70-3-6
    Average 86 stars, based on 1 article reviews
    acl femoral guide - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Inova Diagnostics igm anticardiolipin antibodies acl
    ACLY activity regulates MDR1 expression in colorectal cancer. (A) Transcript levels of ACLY and MDR1 (ABCB1) in colorectal cancer (red) and normal colon tissues (grey) analyzed using GEPIA (TCGA/GTEx datasets). (B) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the ACLY <t>inhibitor</t> <t>BMS-303141</t> (20 or 50 μM, 48 h). (C) Immunoblot analysis of ACLY and MDR1 in SW480 and DLD1 cells transduced with empty vector (pLV) or ACLY-overexpressing vector (pLV[Exp]-hACLY). (D) Immunoblot analysis of ACLY and MDR1 in control and ACLY-overexpressing cells treated with BMS-303141 (50 μM, 48 h). (E) Relative ABCB1 mRNA levels in control and ACLY-overexpressing cells, and in cells treated with BMS-303141. (F) Relative ACLY mRNA levels under the same conditions. Data are presented as mean ± SD (n = 3 unless otherwise indicated). Statistical significance was determined using unpaired two-tailed t-tests or one-way ANOVA with Tukey’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.
    Igm Anticardiolipin Antibodies Acl, supplied by Inova Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/acl+anti+anticardiolipin+igm/pm42278482-170-2-25
    Average 86 stars, based on 1 article reviews
    igm anticardiolipin antibodies acl - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    93
    Alomone Labs primary rabbit anti- anoctamin- 1
    ACLY activity regulates MDR1 expression in colorectal cancer. (A) Transcript levels of ACLY and MDR1 (ABCB1) in colorectal cancer (red) and normal colon tissues (grey) analyzed using GEPIA (TCGA/GTEx datasets). (B) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the ACLY <t>inhibitor</t> <t>BMS-303141</t> (20 or 50 μM, 48 h). (C) Immunoblot analysis of ACLY and MDR1 in SW480 and DLD1 cells transduced with empty vector (pLV) or ACLY-overexpressing vector (pLV[Exp]-hACLY). (D) Immunoblot analysis of ACLY and MDR1 in control and ACLY-overexpressing cells treated with BMS-303141 (50 μM, 48 h). (E) Relative ABCB1 mRNA levels in control and ACLY-overexpressing cells, and in cells treated with BMS-303141. (F) Relative ACLY mRNA levels under the same conditions. Data are presented as mean ± SD (n = 3 unless otherwise indicated). Statistical significance was determined using unpaired two-tailed t-tests or one-way ANOVA with Tukey’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.
    Primary Rabbit Anti Anoctamin 1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/Anti-TMEM16A+(ANO1)+(extracellular)+Antibody/pm42277581-77-29-38
    Average 93 stars, based on 1 article reviews
    primary rabbit anti- anoctamin- 1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    86
    Inova Diagnostics quanta flash acl igg igm
    ACLY activity regulates MDR1 expression in colorectal cancer. (A) Transcript levels of ACLY and MDR1 (ABCB1) in colorectal cancer (red) and normal colon tissues (grey) analyzed using GEPIA (TCGA/GTEx datasets). (B) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the ACLY <t>inhibitor</t> <t>BMS-303141</t> (20 or 50 μM, 48 h). (C) Immunoblot analysis of ACLY and MDR1 in SW480 and DLD1 cells transduced with empty vector (pLV) or ACLY-overexpressing vector (pLV[Exp]-hACLY). (D) Immunoblot analysis of ACLY and MDR1 in control and ACLY-overexpressing cells treated with BMS-303141 (50 μM, 48 h). (E) Relative ABCB1 mRNA levels in control and ACLY-overexpressing cells, and in cells treated with BMS-303141. (F) Relative ACLY mRNA levels under the same conditions. Data are presented as mean ± SD (n = 3 unless otherwise indicated). Statistical significance was determined using unpaired two-tailed t-tests or one-way ANOVA with Tukey’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.
    Quanta Flash Acl Igg Igm, supplied by Inova Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/acl+anti+anticardiolipin+igm/pm42279488-63-8-16
    Average 86 stars, based on 1 article reviews
    quanta flash acl igg igm - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Ossur Americas acl
    Treated <t>ACL</t> healing from tibia to femur (Both panels: Sagittal PD MRI). (A) ACL healing in a knee with femoral tunnel close to the native attachment (anterior-posterior location: 18%). (B) ACL healing in a knee with femoral tunnel further anterior to the native attachment (anterior-posterior location: 40%). Femoral tunnels are highlighted with the white arrows. ACL, <t>anterior</t> <t>cruciate</t> ligament; MRI, magnetic resonance imaging; PD, proton density weighted.
    Acl, supplied by Ossur Americas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/acl/pmc13254427-74-2-6
    Average 86 stars, based on 1 article reviews
    acl - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Abmart Inc antibodies against acly
    Treated <t>ACL</t> healing from tibia to femur (Both panels: Sagittal PD MRI). (A) ACL healing in a knee with femoral tunnel close to the native attachment (anterior-posterior location: 18%). (B) ACL healing in a knee with femoral tunnel further anterior to the native attachment (anterior-posterior location: 40%). Femoral tunnels are highlighted with the white arrows. ACL, <t>anterior</t> <t>cruciate</t> ligament; MRI, magnetic resonance imaging; PD, proton density weighted.
    Antibodies Against Acly, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/acly+anti/pmc12794510-210-47-50
    Average 86 stars, based on 1 article reviews
    antibodies against acly - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    92
    Alomone Labs rabbit anti clc2
    Treated <t>ACL</t> healing from tibia to femur (Both panels: Sagittal PD MRI). (A) ACL healing in a knee with femoral tunnel close to the native attachment (anterior-posterior location: 18%). (B) ACL healing in a knee with femoral tunnel further anterior to the native attachment (anterior-posterior location: 40%). Femoral tunnels are highlighted with the white arrows. ACL, <t>anterior</t> <t>cruciate</t> ligament; MRI, magnetic resonance imaging; PD, proton density weighted.
    Rabbit Anti Clc2, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/Anti-CLC-2+(CLCN2)+Antibody/pm42230621-288-26-28
    Average 92 stars, based on 1 article reviews
    rabbit anti clc2 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    86
    Noyes Inc acl ruptures
    Treated <t>ACL</t> healing from tibia to femur (Both panels: Sagittal PD MRI). (A) ACL healing in a knee with femoral tunnel close to the native attachment (anterior-posterior location: 18%). (B) ACL healing in a knee with femoral tunnel further anterior to the native attachment (anterior-posterior location: 40%). Femoral tunnels are highlighted with the white arrows. ACL, <t>anterior</t> <t>cruciate</t> ligament; MRI, magnetic resonance imaging; PD, proton density weighted.
    Acl Ruptures, supplied by Noyes Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/acl+ruptures/pm42242048-151-4-13
    Average 86 stars, based on 1 article reviews
    acl ruptures - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    95
    Alomone Labs primary antibodies against cftr
    Treated <t>ACL</t> healing from tibia to femur (Both panels: Sagittal PD MRI). (A) ACL healing in a knee with femoral tunnel close to the native attachment (anterior-posterior location: 18%). (B) ACL healing in a knee with femoral tunnel further anterior to the native attachment (anterior-posterior location: 40%). Femoral tunnels are highlighted with the white arrows. ACL, <t>anterior</t> <t>cruciate</t> ligament; MRI, magnetic resonance imaging; PD, proton density weighted.
    Primary Antibodies Against Cftr, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acl/Anti-CFTR+Antibody/pm42153781-57-0-11
    Average 95 stars, based on 1 article reviews
    primary antibodies against cftr - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    ACLY activity regulates MDR1 expression in colorectal cancer. (A) Transcript levels of ACLY and MDR1 (ABCB1) in colorectal cancer (red) and normal colon tissues (grey) analyzed using GEPIA (TCGA/GTEx datasets). (B) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the ACLY inhibitor BMS-303141 (20 or 50 μM, 48 h). (C) Immunoblot analysis of ACLY and MDR1 in SW480 and DLD1 cells transduced with empty vector (pLV) or ACLY-overexpressing vector (pLV[Exp]-hACLY). (D) Immunoblot analysis of ACLY and MDR1 in control and ACLY-overexpressing cells treated with BMS-303141 (50 μM, 48 h). (E) Relative ABCB1 mRNA levels in control and ACLY-overexpressing cells, and in cells treated with BMS-303141. (F) Relative ACLY mRNA levels under the same conditions. Data are presented as mean ± SD (n = 3 unless otherwise indicated). Statistical significance was determined using unpaired two-tailed t-tests or one-way ANOVA with Tukey’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.

    Journal: Neoplasia (New York, N.Y.)

    Article Title: Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerability

    doi: 10.1016/j.neo.2026.101314

    Figure Lengend Snippet: ACLY activity regulates MDR1 expression in colorectal cancer. (A) Transcript levels of ACLY and MDR1 (ABCB1) in colorectal cancer (red) and normal colon tissues (grey) analyzed using GEPIA (TCGA/GTEx datasets). (B) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the ACLY inhibitor BMS-303141 (20 or 50 μM, 48 h). (C) Immunoblot analysis of ACLY and MDR1 in SW480 and DLD1 cells transduced with empty vector (pLV) or ACLY-overexpressing vector (pLV[Exp]-hACLY). (D) Immunoblot analysis of ACLY and MDR1 in control and ACLY-overexpressing cells treated with BMS-303141 (50 μM, 48 h). (E) Relative ABCB1 mRNA levels in control and ACLY-overexpressing cells, and in cells treated with BMS-303141. (F) Relative ACLY mRNA levels under the same conditions. Data are presented as mean ± SD (n = 3 unless otherwise indicated). Statistical significance was determined using unpaired two-tailed t-tests or one-way ANOVA with Tukey’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001.

    Article Snippet: The ACLY inhibitor BMS-303141 (MedChemExpress; HY-16107) was dissolved in DMSO (10 mM stock) and used at 50 μM for 48 h. Vorinostat (MedChemExpress; HY-10221) was dissolved in DMSO and used at 0.5 μM (SW480) or 3.5 μM (DLD1) for 48 h. Sodium ascorbate (Sigma-Aldrich; A7632) was freshly prepared in sterile water (100 mM stock) and used at 5 mM for 6 h unless otherwise indicated.

    Techniques: Activity Assay, Expressing, Western Blot, Transduction, Plasmid Preparation, Control, Two Tailed Test

    ACLY activity modulates histone acetylation and MDR1 expression. (A) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the histone deacetylase inhibitor vorinostat (VOR; 0.5 μM for SW480 and 3.5 μM for DLD1) or DMSO for 24 h. Representative blots and densitometric quantification relative to control are shown. (B) Immunoblot analysis of acetylated histone H3 (H3K9ac) and histone H4 (H4K16ac) in SW480 wild-type (WT) and ACLY-overexpressing (OE) cells treated with vehicle or the ACLY inhibitor BMS-303141 (50 μM, 48 h). (C) Immunoblot analysis of H3K9ac and H4K16ac in DLD1 cells under the same conditions. β-actin was used as a loading control. Data are presented as mean ± SD (n = 3). Statistical significance was determined using unpaired two-tailed t-tests. *P < 0.05; **P < 0.01; ***P < 0.001.

    Journal: Neoplasia (New York, N.Y.)

    Article Title: Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerability

    doi: 10.1016/j.neo.2026.101314

    Figure Lengend Snippet: ACLY activity modulates histone acetylation and MDR1 expression. (A) Immunoblot analysis of MDR1 in SW480 and DLD1 cells treated with the histone deacetylase inhibitor vorinostat (VOR; 0.5 μM for SW480 and 3.5 μM for DLD1) or DMSO for 24 h. Representative blots and densitometric quantification relative to control are shown. (B) Immunoblot analysis of acetylated histone H3 (H3K9ac) and histone H4 (H4K16ac) in SW480 wild-type (WT) and ACLY-overexpressing (OE) cells treated with vehicle or the ACLY inhibitor BMS-303141 (50 μM, 48 h). (C) Immunoblot analysis of H3K9ac and H4K16ac in DLD1 cells under the same conditions. β-actin was used as a loading control. Data are presented as mean ± SD (n = 3). Statistical significance was determined using unpaired two-tailed t-tests. *P < 0.05; **P < 0.01; ***P < 0.001.

    Article Snippet: The ACLY inhibitor BMS-303141 (MedChemExpress; HY-16107) was dissolved in DMSO (10 mM stock) and used at 50 μM for 48 h. Vorinostat (MedChemExpress; HY-10221) was dissolved in DMSO and used at 0.5 μM (SW480) or 3.5 μM (DLD1) for 48 h. Sodium ascorbate (Sigma-Aldrich; A7632) was freshly prepared in sterile water (100 mM stock) and used at 5 mM for 6 h unless otherwise indicated.

    Techniques: Activity Assay, Expressing, Western Blot, Histone Deacetylase Assay, Control, Two Tailed Test

    ACLY expression is associated with resistance-related transcriptional programs in colorectal cancer. (A) Correlation analysis between ACLY expression and a gene set associated with lipid metabolism (ACLY, ACSS2, ACSS1, FASN, SREBP1) and drug transport pathways (ABCB1, ABCC2, ABCG5, EpCAM, CD24) in colorectal cancer samples using GEPIA2 (TCGA dataset). (B) Schematic representation of a proposed model linking ACLY-dependent acetyl-CoA production to histone acetylation and transcriptional regulation in CRC cells. (C) Relative mRNA expression of EpCAM, ABCC2, and CD24 in SW480 and DLD1 cells overexpressing ACLY compared with empty vector controls. (D) Relative mRNA expression of EpCAM, ABCC2, and CD24 in SW480 and DLD1 cells treated with the ACLY inhibitor BMS-303141 (50 μM) compared with vehicle-treated controls. Gene expression levels were determined by qPCR and normalized to ACTB. Data are presented as mean ± SEM (n = 3). Statistical significance was determined using unpaired two-tailed t-tests. *P < 0.05; **P < 0.01; ***P < 0.001.

    Journal: Neoplasia (New York, N.Y.)

    Article Title: Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerability

    doi: 10.1016/j.neo.2026.101314

    Figure Lengend Snippet: ACLY expression is associated with resistance-related transcriptional programs in colorectal cancer. (A) Correlation analysis between ACLY expression and a gene set associated with lipid metabolism (ACLY, ACSS2, ACSS1, FASN, SREBP1) and drug transport pathways (ABCB1, ABCC2, ABCG5, EpCAM, CD24) in colorectal cancer samples using GEPIA2 (TCGA dataset). (B) Schematic representation of a proposed model linking ACLY-dependent acetyl-CoA production to histone acetylation and transcriptional regulation in CRC cells. (C) Relative mRNA expression of EpCAM, ABCC2, and CD24 in SW480 and DLD1 cells overexpressing ACLY compared with empty vector controls. (D) Relative mRNA expression of EpCAM, ABCC2, and CD24 in SW480 and DLD1 cells treated with the ACLY inhibitor BMS-303141 (50 μM) compared with vehicle-treated controls. Gene expression levels were determined by qPCR and normalized to ACTB. Data are presented as mean ± SEM (n = 3). Statistical significance was determined using unpaired two-tailed t-tests. *P < 0.05; **P < 0.01; ***P < 0.001.

    Article Snippet: The ACLY inhibitor BMS-303141 (MedChemExpress; HY-16107) was dissolved in DMSO (10 mM stock) and used at 50 μM for 48 h. Vorinostat (MedChemExpress; HY-10221) was dissolved in DMSO and used at 0.5 μM (SW480) or 3.5 μM (DLD1) for 48 h. Sodium ascorbate (Sigma-Aldrich; A7632) was freshly prepared in sterile water (100 mM stock) and used at 5 mM for 6 h unless otherwise indicated.

    Techniques: Expressing, Drug Transport Assay, Plasmid Preparation, Gene Expression, Two Tailed Test

    Treated ACL healing from tibia to femur (Both panels: Sagittal PD MRI). (A) ACL healing in a knee with femoral tunnel close to the native attachment (anterior-posterior location: 18%). (B) ACL healing in a knee with femoral tunnel further anterior to the native attachment (anterior-posterior location: 40%). Femoral tunnels are highlighted with the white arrows. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Treated ACL healing from tibia to femur (Both panels: Sagittal PD MRI). (A) ACL healing in a knee with femoral tunnel close to the native attachment (anterior-posterior location: 18%). (B) ACL healing in a knee with femoral tunnel further anterior to the native attachment (anterior-posterior location: 40%). Femoral tunnels are highlighted with the white arrows. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Magnetic Resonance Imaging

    Violin plots indicating the longitudinal changes in ACL orientation, size, and normalized signal intensity from 6 to 24 months after surgery, and compared with the contralateral native ACL (CTRL). PD images were used to measure sagittal elevation angle, and CISS was used to assess tissue quality and size. Dash lines indicate the median and interquartile range. Significant P -values are shown. ACL, anterior cruciate ligament; CISS, constructive interference in steady state; CTRL, control/contralateral native ACL; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Violin plots indicating the longitudinal changes in ACL orientation, size, and normalized signal intensity from 6 to 24 months after surgery, and compared with the contralateral native ACL (CTRL). PD images were used to measure sagittal elevation angle, and CISS was used to assess tissue quality and size. Dash lines indicate the median and interquartile range. Significant P -values are shown. ACL, anterior cruciate ligament; CISS, constructive interference in steady state; CTRL, control/contralateral native ACL; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Control

    Six-, 12-, and 24-month postoperative images of a patient who underwent ACL restoration—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI—demonstrating above-average healing. Progressively lower signal in intact fibers is observed at all time points, including a near-normal ACL appearance at 24 months (white arrows). ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Six-, 12-, and 24-month postoperative images of a patient who underwent ACL restoration—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI—demonstrating above-average healing. Progressively lower signal in intact fibers is observed at all time points, including a near-normal ACL appearance at 24 months (white arrows). ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Magnetic Resonance Imaging

    Six-, 12-, and 24-month postoperative images of a patient who underwent ACL restoration—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI—demonstrating average healing. Low-signal intact fibers are seen throughout all time points, including a near-normal ACL appearance at 24 months (white arrows). There is increased fluid signal intensity extending into Hoffa's fat pad (red arrows), indicating associated edema, which improved over time. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Six-, 12-, and 24-month postoperative images of a patient who underwent ACL restoration—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI—demonstrating average healing. Low-signal intact fibers are seen throughout all time points, including a near-normal ACL appearance at 24 months (white arrows). There is increased fluid signal intensity extending into Hoffa's fat pad (red arrows), indicating associated edema, which improved over time. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Magnetic Resonance Imaging

    Six-, 12-, and 24-month postoperative images of a patient who underwent ACL restoration—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI—demonstrating below-average healing. Despite associated edema extending into Hoffa's fat pad throughout (red arrows), the ACL has interval improvement with intact fibers from the femoral to tibial attachments (white arrows). ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Six-, 12-, and 24-month postoperative images of a patient who underwent ACL restoration—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI—demonstrating below-average healing. Despite associated edema extending into Hoffa's fat pad throughout (red arrows), the ACL has interval improvement with intact fibers from the femoral to tibial attachments (white arrows). ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Magnetic Resonance Imaging

    Six-, 9-, and 12-month postoperative images of a patient who underwent ACL restoration and experienced a tear after a normal healing trajectory—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI. (A, D) Intact fibers are seen at 6 months, but (B, E) after an injurious event, there is greater signal heterogeneity, and intact fibers cannot be followed from the femoral to tibial attachments (white arrows). (C, F) At 12 months, the ACL had a notably more horizontal appearance than expected. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Six-, 9-, and 12-month postoperative images of a patient who underwent ACL restoration and experienced a tear after a normal healing trajectory—(A-C) top panels: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI. (A, D) Intact fibers are seen at 6 months, but (B, E) after an injurious event, there is greater signal heterogeneity, and intact fibers cannot be followed from the femoral to tibial attachments (white arrows). (C, F) At 12 months, the ACL had a notably more horizontal appearance than expected. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Magnetic Resonance Imaging

    Six-, 12-, and 14-month postoperative images of a patient who underwent ACL restoration and demonstrated poor healing—(A-C) top panel: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI. There is increased fluid signal intensity noted in the intercondylar notch, indicating fibrosis, and no intact ACL fibers can be followed from the femoral to tibial attachments (white arrows). ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Six-, 12-, and 14-month postoperative images of a patient who underwent ACL restoration and demonstrated poor healing—(A-C) top panel: sagittal PD MRI, (D-F) bottom panels: sagittal T2 MRI. There is increased fluid signal intensity noted in the intercondylar notch, indicating fibrosis, and no intact ACL fibers can be followed from the femoral to tibial attachments (white arrows). ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Magnetic Resonance Imaging

    Twenty-four–month postoperative images of a patient who underwent ACL restoration and demonstrated a lack of femoral stump integration—(A) left panel: sagittal PD MRI, (B) right panel: sagittal T2 MRI. There is a clear separation (yellow arrows) between the ACL tissue connecting the tibia to the femoral tunnel (white arrows) and the ACL fibers coming from the native femoral insertion (red arrows). Despite the appearance of 2 separate strands, the patient did well clinically and did not require revision. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Journal: Orthopaedic Journal of Sports Medicine

    Article Title: Magnetic Resonance Imaging Assessment of Bridge-Enhanced ACL Restoration: An Imaging Atlas of Morphological Features and Healing Trajectories

    doi: 10.1177/23259671261445974

    Figure Lengend Snippet: Twenty-four–month postoperative images of a patient who underwent ACL restoration and demonstrated a lack of femoral stump integration—(A) left panel: sagittal PD MRI, (B) right panel: sagittal T2 MRI. There is a clear separation (yellow arrows) between the ACL tissue connecting the tibia to the femoral tunnel (white arrows) and the ACL fibers coming from the native femoral insertion (red arrows). Despite the appearance of 2 separate strands, the patient did well clinically and did not require revision. ACL, anterior cruciate ligament; MRI, magnetic resonance imaging; PD, proton density weighted.

    Article Snippet: A functional ACL brace (CTi brace; OSSUR) or a simple hinged knee brace was recommended for 6 to 12 weeks, with the functional knee brace recommended for cutting and pivoting sports for 2 years after surgery.

    Techniques: Magnetic Resonance Imaging